title: Accelerated degradation of acetylcholine receptor from cultured rat myotubes with myasthenia gravis sera and globulins.
abstract: Altered geometry of the neuromuscular junction and a decreased number of acetylcholine receptors appear responsible for the defect of neuromuscular transmission in myasthenia gravis. We have used cultured rat myotubes as a model to study in vitro the potential role of myasthenic globulins in the pathological process. Acetylcholine receptor content was assayed by the extent of 125I-labeled alpha-bungarotoxin binding, and acetylcholine receptor function was assayed by the sensitivity to acetylcholine iontophoresis. The half-life of the acetylcholine receptor was 18.5 hr in the presence or absence of control sera. Myasthenic sera and globulins produced a gradual reduction in acetylcholine receptors, as assessed by biochemical and electrophysiological techniques. The half-life in the presence of myasthenic sera was 6 hr. The accelerated turnover was unaffected by puromycin but was slowed by lowered temperature (18-20 degrees), interference with energy metabolism (2,4-dinitrophenol), and interference with cytoskeletal structures (colchicine and cytochalasin B). We found no electrophysiological evidence to suggest globulin blockade of acetylcholine access to the acetylcholine receptor. Our observations suggest that circulating globulins in myasthenia gravis may contribute to the functional defects of neuromuscular transmission by accelerating the rate of internationalization and degradation of surface membrane acetylcholine receptors.
mesh_terms: D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D000937:Antigen-Antibody Reactions; D002038:Bungarotoxins / Q000378:metabolism; D002478:Cells, Cultured; D003078:Colchicine / Q000494:pharmacology; D003571:Cytochalasin B / Q000494:pharmacology; D004140:Dinitrophenols / Q000494:pharmacology; D007518:Isoantibodies; D008564:Membrane Potentials / Q000187:drug effects; D009132:Muscles / Q000276:immunology* / Q000378:metabolism; D009157:Myasthenia Gravis / Q000276:immunology*; D051381:Rats; D011950:Receptors, Cholinergic / Q000378:metabolism*; D011978:Receptors, Nicotinic / Q000187:drug effects / Q000378:metabolism*; D013696:Temperature
chemical_list: D002038:Bungarotoxins; D004140:Dinitrophenols; D007518:Isoantibodies; D011950:Receptors, Cholinergic; D011978:Receptors, Nicotinic; D003571:Cytochalasin B; D000109:Acetylcholine; D003078:Colchicine
references.citation: J Clin Invest. 1976 Dec;58(6):1442-9
references.pmid: 993353
references.citation: Nature. 1976 Nov 4;264(5581):74-6
references.pmid: 1004540
references.citation: J Physiol. 1975 Nov;252(3):771-89
references.pmid: 1206575
references.citation: Eur J Immunol. 1972 Jun;2(3):203-12
references.pmid: 4569167
references.citation: Lancet. 1975 Mar 15;1(7907):607-9
references.pmid: 47950
references.citation: J Exp Med. 1973 Mar 1;137(3):675-89
references.pmid: 4540168
references.citation: J Cell Biol. 1975 May;65(2):335-58
references.pmid: 236319
references.citation: Ann N Y Acad Sci. 1976;274:319-36
references.pmid: 183587
references.citation: Exp Neurol. 1976 Jun;51(3):536-63
references.pmid: 179836
references.citation: Science. 1974 Oct 4;186(4158):55-7
references.pmid: 4421998
references.citation: Nature. 1974 Jul 5;250(461):54-6
references.pmid: 4841158
references.citation: Science. 1973 Oct 19;182(4109):293-5
references.pmid: 4742736
references.citation: Science. 1973 May 25;180(4088):871-2
references.pmid: 4706680
references.citation: Ann N Y Acad Sci. 1971 Sep 15;183:46-63
references.pmid: 5287834
references.citation: Ann N Y Acad Sci. 1976;274:60-79
references.pmid: 1066997
references.citation: Ann N Y Acad Sci. 1976;274:475-92
references.pmid: 1066995
references.citation: Ann N Y Acad Sci. 1976;274:275-82
references.pmid: 1066989
references.citation: Ann N Y Acad Sci. 1976;274:254-74
references.pmid: 1066988
references.citation: Proc Natl Acad Sci U S A. 1975 Nov;72(11):4430-4
references.pmid: 1060123
references.citation: Science. 1975 Oct 24;190(4212):397-9
references.pmid: 1179220
references.citation: N Engl J Med. 1975 Oct 9;293(15):760-1
references.pmid: 1160955
references.citation: Biochim Biophys Acta. 1975 May 30;393(1):66-77
references.pmid: 1138925
references.citation: Nature. 1975 Feb 20;253(5493):643-4
references.pmid: 1113859
references.citation: Exp Cell Res. 1975 Mar 1;91(1):125-42
references.pmid: 1132413
references.citation: Proc Natl Acad Sci U S A. 1968 Oct;61(2):477-83
references.pmid: 5245982